Danwang Medical

About:

Danwang Medical is a research organization focusing on regenerative medicine and organoid technology.

Website: http://www.d1med.com/

Top Investors: Delian Capital, Guofang Capital, Kunlun Capital

Description:

Danwang Medical provides clinical transformation technology services to regenerative medicine for disease diagnosis and treatments. They also provide organoid drug sensitivity testing, organoid disease models, organoid drug development, and organoid chips. Danwang Medical is committed to applying the most recent clinical transformation technology of regenerative medicine to disease diagnosis and treatment, new drug screening, tumor marker development and identification, and other areas in order to provide clinical personalized treatment technology and accurate, efficient, and high-quality organoids Model to new drug research and development enterprises.

Total Funding Amount:

120M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2019-01-01

Contact Email:

service(AT)d1med.com

Founders:

Junqiang Li

Number of Employees:

Last Funding Date:

2021-10-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai